Skip to main content

Table 3 Availability of misoprostol prevention doses: % (95% CI)

From: Scaling up interventions: findings and lessons learned from an external evaluation of Niger’s National Initiative to reduce postpartum hemorrhage

 

Phase 1 (n = 60)

Phase 2 (n = 60)

p-value

Received at least 1 procurement

96.5 (92.3, 98.5)

98.2 (96.3, 99.2)

P = .23

Experienced stock out within the last 12 months

23.5 (10.0, 45.9)

28.7 (16.8, 44.5)

p = .64

Stock out duration within last 12 months

 Never

76.5 (54.1, 90.0)

72.7 (56.4, 84.5)

p = .68

 Less than 1 month

12.9 (4.6, 31.1)

19.8 (9.5, 36.7)

 1–3 months

9.2 (2.4, 29.1)

7.5 (3.1, 17.3)

 Over 3 months

1.4 (0.2, 10.2)

0

Expired stock at time of data collection

18 (7.3, 38.1)

20.4 (9.6, 38.4)

P = .81